HYPERTRIGLYCERIDEMIA SYNDROME: A CASE REPORT
Abstract
Severe hypertriglyceridemia is associated with a number of severe diseases such as acute pancreatitis, coronary artery disease and hepatosplenomegaly. The treatment aims at rapidly decreasing the serum triglyceride level; the treatment includes reduced fat diet, hypoglycemic agents, option for the treatment of acute pancreatitis and for the prevention of relapses when the clinical treatment fails, and it must be done as soon as possible.
Downloads
References
Moreton JR. Atherosclerosis and alimentary hyperlipemia. Science. 1947,106:190–191.DOI:10.1126/science.106.2748.190
Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995;90:2134–2139.
Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990;19:783–79.
Anderson F, Thomson SR, Clarke DL, Buccimazza I. Dyslipidaemic pancreatitis clinical assessment and analysis of disease severity and outcomes. Pancreatol. 2009;9:252–257. DOI:10.1159/000212091
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969-89. DOI: 10.1210/jc.2011-3213
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW et al. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endoc Pract. 2012;18(Suppl 1):1-78. DOI: 10.4158/EP171764.APPGL
Perkumpulan Endokrinologi Indonesia. Konsensus Pengelolaan Dislipidemia diIndonesia. Jakarta:Pusat PenerbitanI lmu Penya kit Dalam Fakultas Kedokteran; 2012.
Hegele RA, Ginbersg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014;2(8):655–666. DOI: 10.1016/S2213-8587(13)70191-8
Ewald N, Kloer HU. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis. Clin Res Cardiol Suppl. 2012; 7:31-5. DOI: 10.1007/s11789-012-0042-x
Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN et al.; American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292-333. DOI: 10.1161/CIR.0b013e3182160726.
Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl. 2009;10:49-52. DOI: 10.1016/S1567-5688(09)71810-0
Ewald N, Kloer HU. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis. Clin Res Cardiol Suppl. 2012:31-5. DOI: 10.1007/ s11789-012-0042-x.
Ewald N, Kloer HU. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis. Clin Res Cardiol Suppl. 2012:31-5. 10.1007/ s11789-012-0042-x
Yeh JH, Lee MF, Chiu HC. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants. J Clin Apher. 2003;18:32-6. DOI:10. 1002/jca.10047.
Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr. 2000; 54(suppl 1): S47. DOI: 10.1038/sj.ejcn.1600984
Ferreira AF, Bartelega JA, Urbano HCA, Souza IKF. Fatores preditivos de gravidade da pancreatite aguda: quais e quando utilizar?Arq Bras Cir Dig. 2015; 28(3): 207-11. DOI: 10.1590/S0102-67202015000300016
Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995;90(12): 2134-9.
Downloads
Published
Issue
Section
License
Os artigos submetidos à revista Colloquium Vitae estão licenciados conforme CC BY-NC-ND. Para mais informações sobre essa forma de Licenciamento, consulte: http://creativecommons.org/licenses/by-nc-nd/4.0/.
A disponibilização é gratuita na Internet, para que os usuários possam ler, fazer download, copiar, distribuir, imprimir, pesquisar ou referenciar o texto integral dos documentos, processá-los para indexação, utilizá-los como dados de entrada de programas para softwares, ou usá-los para qualquer outro propósito legal, sem barreira financeira, legal ou técnica.
